These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 15830388)
1. How much do Pseudomonas biofilms contribute to symptoms of pulmonary exacerbation in cystic fibrosis? VanDevanter DR; Van Dalfsen JM Pediatr Pulmonol; 2005 Jun; 39(6):504-6. PubMed ID: 15830388 [TBL] [Abstract][Full Text] [Related]
2. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response. Ciofu O APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154 [TBL] [Abstract][Full Text] [Related]
3. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967 [TBL] [Abstract][Full Text] [Related]
4. Influence of biofilm formation in the susceptibility of Pseudomonas aeruginosa from Brazilian patients with cystic fibrosis. Ferreira AG; Leão RS; Carvalho-Assef AP; Folescu TW; Barth AL; Marques EA APMIS; 2010 Aug; 118(8):606-12. PubMed ID: 20666742 [TBL] [Abstract][Full Text] [Related]
12. Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model. Tré-Hardy M; Macé C; El Manssouri N; Vanderbist F; Traore H; Devleeschouwer MJ Int J Antimicrob Agents; 2009 Jan; 33(1):40-5. PubMed ID: 18801647 [TBL] [Abstract][Full Text] [Related]
13. Anaerobic culture conditions favor biofilm-like phenotypes in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. O'May CY; Reid DW; Kirov SM FEMS Immunol Med Microbiol; 2006 Dec; 48(3):373-80. PubMed ID: 17052266 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa. Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804 [TBL] [Abstract][Full Text] [Related]
15. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571 [TBL] [Abstract][Full Text] [Related]
16. Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients. García-Castillo M; del Campo R; Baquero F; Morosini MI; Turrientes MC; Zamora J; Cantón R Clin Microbiol Infect; 2011 May; 17(5):704-11. PubMed ID: 20673272 [TBL] [Abstract][Full Text] [Related]
17. Delivery of photosensitisers and light through mucus: investigations into the potential use of photodynamic therapy for treatment of Pseudomonas aeruginosa cystic fibrosis pulmonary infection. Donnelly RF; McCarron PA; Cassidy CM; Elborn JS; Tunney MM J Control Release; 2007 Feb; 117(2):217-26. PubMed ID: 17196290 [TBL] [Abstract][Full Text] [Related]
18. The approach to Pseudomonas aeruginosa in cystic fibrosis. Bendiak GN; Ratjen F Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546 [TBL] [Abstract][Full Text] [Related]
19. Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes. Nguyen D; Emond MJ; Mayer-Hamblett N; Saiman L; Marshall BC; Burns JL Pediatr Pulmonol; 2007 Jun; 42(6):533-41. PubMed ID: 17469154 [TBL] [Abstract][Full Text] [Related]
20. Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment of Pseudomonas aeruginosa biofilm infections. Ciofu O; Mandsberg LF; Wang H; Høiby N FEMS Immunol Med Microbiol; 2012 Jul; 65(2):215-25. PubMed ID: 22540844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]